Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Veterans Affairs was posted on October 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Imatinib Tablets

Closed
36E79726R0036Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.

General Info

VA seeks fixed price contract for Imatinib Mesylate Tablets for various federal entities.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

3
DOCX, High priority: read this first38 pages · rfp
High
DOCX, Low priority3 pages · presolicitation
Low
PDF, Low priority9 pages · other
Low

Read all 3 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • FY27 PharmacyOpen now
  • FY27 PharmacyOpen now
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA

Full Description

Show more
N/A

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
RFP - Filgrastim Syringes or Biosimilar
Solicitation # 36E79727R0001
The Department of Veterans Affairs is soliciting proposals for the procurement of Filgrastim 300mcg and 480mcg non-safety syringes or biosimilars. This unrestricted procurement is intended to support the VA, DoD, BOP, IHS, and FHCC. The contract structure consists of an implementation period followed by a one-year base ordering period and four one-year pre-priced option periods. Award will be based on the lowest evaluated price for proposals that meet technical acceptability standards, which include FDA approval, verifiable cGMP status, and a unique NDC number for each offered product. Pricing is evaluated on a per-syringe basis and must remain identical across all offered commercial package sizes. The contractor must ensure all pharmaceutical products include bar code labeling at the unit-of-use package level conforming to GS1-128 or HIBC standards, and must comply with the Drug Supply Chain Security Act by providing two-dimensional data matrix bar codes and serialized transaction information. Distribution will be managed through Government Prime Vendor contracts with delivery terms set as FOB Destination. Offerors who are not the manufacturer must provide a Letter of Commitment to ensure a sufficient source of supply for the duration of the contract. Proposals must be submitted via email in PDF or Microsoft Word format, including a signed SF-1449 and the offeror's Unique Entity Identifier and CAGE code.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 17 days
View Details

Get AI-powered intelligence on the opportunities still open

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS